Parkinson's disease, The Lancet, vol.373, issue.9680, pp.2055-206660492, 2009. ,
DOI : 10.1016/S0140-6736(09)60492-X
Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance, Journal of Neurochemistry, vol.89, issue.3 Pt 1, pp.59-7410, 2016. ,
DOI : 10.1016/j.ajhg.2011.06.008
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155439
LRRK2 Pathways Leading to Neurodegeneration Current Neurology and neuroscience reports 15, 2015. ,
DOI : 10.1007/s11910-015-0564-y
Mechanisms in dominant parkinsonism: The toxic triangle of LRRK2, ??-synuclein, and tau, BioEssays, vol.192, issue.128, pp.227-23510, 2010. ,
DOI : 10.1080/07391102.2003.10506918
The Genetics of Parkinson Disease, Journal of Geriatric Psychiatry and Neurology, vol.23, issue.4, pp.228-24210, 2010. ,
DOI : 10.1002/mds.21751
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology, Neuron, vol.44, issue.4, pp.601-607, 2004. ,
DOI : 10.1016/j.neuron.2004.11.005
URL : http://doi.org/10.1016/j.neuron.2004.11.005
Targeting leucine-rich repeat kinase 2 in Parkinson's disease, Expert Opinion on Therapeutic Targets, vol.65, issue.1, pp.1471-1482, 2013. ,
DOI : 10.1212/01.WNL.0000172630.22804.73
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2, Nature Chemical Biology, vol.269, issue.4, pp.203-20510, 2011. ,
DOI : 10.1016/0014-5793(95)00357-F
Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease, Trends in Pharmacological Sciences, vol.33, issue.7, pp.365-373, 2012. ,
DOI : 10.1016/j.tips.2012.04.001
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?, Current Neuropharmacology, vol.14, issue.3, pp.214-225, 2016. ,
DOI : 10.2174/1570159X13666151030102847
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857626
Roc, a Ras/GTPase domain in complex proteins, GTPase domain in complex proteins, pp.5-10, 2003. ,
DOI : 10.1016/j.bbamcr.2003.08.008
URL : http://doi.org/10.1016/j.bbamcr.2003.08.008
Prediction of the repeat domain structures and impact of parkinsonism-associated variations on structure and function of all functional domains of leucine ,
Mutant LRRK2 Elicits Calcium Imbalance and Depletion of Dendritic Mitochondria in Neurons, The American Journal of Pathology, vol.182, issue.2, pp.474-484027, 2013. ,
DOI : 10.1016/j.ajpath.2012.10.027
Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP, Human Molecular Genetics, vol.21, issue.3, pp.511-525, 2012. ,
DOI : 10.1093/hmg/ddr481
The Familial Parkinsonism Gene LRRK2 Regulates Neurite Process Morphology, Neuron, vol.52, issue.4, pp.587-593008, 2006. ,
DOI : 10.1016/j.neuron.2006.10.008
Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant, Journal of Neurochemistry, vol.6, issue.2, pp.304-315, 2011. ,
DOI : 10.1016/j.bbadis.2009.09.010
The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation, Journal of Biological Chemistry, vol.61, issue.Suppl. 7, pp.16906-16914, 2008. ,
DOI : 10.1074/jbc.M004092200
Dependence of Leucine-rich Repeat Kinase 2 (LRRK2) Kinase Activity on Dimerization, Journal of Biological Chemistry, vol.1, issue.52, pp.36346-36356, 2009. ,
DOI : 10.1186/1471-2202-8-102
The GTPase function of LRRK2, Biochemical Society Transactions, vol.10, issue.5, pp.1063-106910, 2012. ,
DOI : 10.1186/1741-7015-10-20
Biochemical Characterization of Highly Purified Leucine-Rich Repeat Kinases 1 and 2 Demonstrates Formation of Homodimers, PLoS ONE, vol.7, issue.8, p.43472, 2012. ,
DOI : 10.1371/journal.pone.0043472.s011
Human leucine-rich repeat kinase 1 and 2: intersecting or unrelated functions?, Biochemical Society Transactions, vol.7, issue.5, pp.1095-1101, 2012. ,
DOI : 10.1038/nrn2038
URL : http://www.biochemsoctrans.org/content/ppbiost/40/5/1095.full.pdf
Differential protein-protein interactions of LRRK1 and LRRK2 indicate roles in distinct cellular signaling pathways, Journal of Neurochemistry, vol.44, issue.Suppl 2, pp.239-25010, 2014. ,
DOI : 10.1016/j.neuron.2004.11.005
Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson???s disease, Neurogenetics, vol.9, issue.2, pp.95-10210, 2007. ,
DOI : 10.1007/s10048-006-0075-8
Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase, Proceedings of the National Academy of Sciences, vol.26, issue.Pt 3, pp.1499-150410, 2008. ,
DOI : 10.1107/S0021889892009944
Roco kinase structures give insights into the mechanism of Parkinson disease-related leucine-rich-repeat kinase 2 mutations, Proceedings of the National Academy of Sciences, vol.53, issue.Pt 3, pp.10322-1032710, 2012. ,
DOI : 10.1107/S0907444996012255
Structure of the Roc???COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase, The EMBO Journal, vol.44, issue.16, pp.2239-2249150, 2008. ,
DOI : 10.1038/emboj.2008.150
Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1824, issue.3, pp.450-460, 2012. ,
DOI : 10.1016/j.bbapap.2011.12.009
Structural model of the dimeric Parkinson???s protein LRRK2 reveals a compact architecture involving distant interdomain contacts, Proceedings of the National Academy of Sciences, vol.113, issue.30, pp.4357-436610, 2016. ,
DOI : 10.1002/prot.23188
ProteoPlex: stability optimization of macromolecular complexes by sparse-matrix screening of chemical space, Nature Methods, vol.12, issue.9, pp.859-86510, 2015. ,
DOI : 10.1021/bi301591e
Optimization of protein buffer cocktails using Thermofluor, Acta Crystallographica Section F Structural Biology and Crystallization Communications, vol.103, issue.2, pp.209-21410, 2013. ,
DOI : 10.1073/pnas.0605224103
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564630
How good can cryo-EM become?, Nature Methods, vol.20, issue.1, pp.28-323695, 2016. ,
DOI : 10.1016/j.str.2012.02.017
URL : http://www.nature.com/nmeth/journal/v13/n1/pdf/nmeth.3695.pdf
Cryo-electron microscopy of vitrified specimens, Quarterly Reviews of Biophysics, vol.1, issue.3, pp.129-228, 1988. ,
DOI : 10.1038/164666a0
RELION: Implementation of a Bayesian approach to cryo-EM structure determination, Journal of Structural Biology, vol.180, issue.3, pp.519-530006, 2012. ,
DOI : 10.1016/j.jsb.2012.09.006
Has negative staining still a place in biomacromolecular electron microscopy?, Ultramicroscopy, vol.46, issue.1-4, pp.85-111, 1992. ,
DOI : 10.1016/0304-3991(92)90008-8
Leucine-Rich Repeat Kinase 2 Binds to Neuronal Vesicles through Protein Interactions Mediated by Its C-Terminal WD40 Domain, Molecular and Cellular Biology, vol.34, issue.12, pp.2147-216100914, 2014. ,
DOI : 10.1128/MCB.00914-13
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054300
Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brain, Journal of Neurochemistry, vol.44, issue.1, pp.1242-125610, 2015. ,
DOI : 10.1016/j.neuron.2004.11.005
The Chaperone Activity of Heat Shock Protein 90 Is Critical for Maintaining the Stability of Leucine-Rich Repeat Kinase 2, Journal of Neuroscience, vol.28, issue.13, pp.3384-3391, 2008. ,
DOI : 10.1523/JNEUROSCI.0185-08.2008
A Direct Interaction between Leucine-rich Repeat Kinase 2 and Specific ??-Tubulin Isoforms Regulates Tubulin Acetylation, Journal of Biological Chemistry, vol.289, issue.2, pp.895-90810, 2014. ,
DOI : 10.1002/ana.23829
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3887213
Conformational heterogeneity of the Roc domains in C. tepidum Roc-COR and implications for human LRRK2 Parkinson mutations, Bioscience Reports, vol.35, issue.5, pp.10-1042, 2015. ,
DOI : 10.1042/BSR20150128
Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment, Journal of Neurochemistry, vol.44, issue.3, pp.703-715, 2009. ,
DOI : 10.1212/01.WNL.0000125015.06989.DB
LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding, PLoS ONE, vol.267, issue.8, 2011. ,
DOI : 10.1371/journal.pone.0023207.s003
carriers, Neurology, vol.86, issue.11, pp.994-99910, 2016. ,
DOI : 10.1212/WNL.0000000000002436
EMAN2: An extensible image processing suite for electron microscopy, Journal of Structural Biology, vol.157, issue.1, pp.38-46, 2007. ,
DOI : 10.1016/j.jsb.2006.05.009
UCSF Chimera?A visualization system for exploratory research and analysis, Journal of Computational Chemistry, vol.373, issue.13, pp.1605-161210, 2004. ,
DOI : 10.1002/jcc.20084
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.456.9442
High resolution single particle refinement in EMAN2, pp.25-34, 2016. ,
DOI : 10.1016/j.ymeth.2016.02.018